Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It will rebound very hard soon.
Just curious how you see this as `interesting ` when it consistently goes down like 10% every day! What attracts you to enter the fray here?
I took a position here. Very interesting!
Hi Golden,
do you already have any entry level for TTOO?
THANK YOU.
Good looking short play here...will be taking a position soon on it
I see this place too, is all lies. Welcome to the United States
I lost my ass here! I can't even keep track of how many reverse splits they've done.. but now I have 12 shares left. Biggest loss of my life
Ttoo
Great stock. Since reverse split of $17.00. Its now worth 70% less in one month down to $5.00.
In one more month at this rate this POS stock will be worth. $1.50 Go Gail!
Ttoo
I didn’t see any laughing on Monday
I didn’t see any laughing on Tuesday
I certainly don’t see any laughing for another 12 months until this POS stock does another RS....
$TTOO Have a good weekend bulls.. Looking forward to the good laughs on Monday from all the clowns over the weekend that have nothing better to do than try and bash people all weekend.
Ttoo
Ttoo is just another way of saying DEBT!
Rinse and repeat. This will be 10 cents in 6 months. just like last year....
It's a common human behavior pattern to sell low and buy high, but let's look at the facts: T2's price dropped from $6 to $0.06 not long ago. After the reverse split (RS), the float is cleaner, and no reported dilution or CRG sales. The BioPanel is cleared for federal sale, and BARDA's positive tweet is significant. Shorts predicted otherwise, but FUD often doesn't age well. In my opinion, now is the time to buy, not sell. Expect news soon.
it moving back up after the…
..
manipulation. post hours are looking good so far.
and grabbed a tad more on the further dip.
We are OFF of the NON-COMPLIANT LIST. ;)
TTOO is a scam existing on selling shares..
and in response, more UNDENIABLE DUMPING
Ttoo
Wow. Your pic looks like my donkeys ass!
Two new news pieces this week:
https://www.globenewswire.com/news-release/2023/10/24/2766016/32489/en/T2-Biosystems-Highlights-New-Clinical-Data-Presented-at-IDWeek-2023-Conference.html
https://www.globenewswire.com/news-release/2023/10/23/2764791/32489/en/T2-Biosystems-Announces-Amendment-and-Extension-of-CRG-Term-Loan-Agreement.html
#TTOO 🔥 can it reach 10 soon? $TTOO
The news doesn’t exist, got it. Thank you.
it's just the beginning of the climb...
the minimum was $5 as I wrote...
Where is the news you said would come Monday or Tuesday?
Only some gamblers can buy TTOO stock but experienced traders do not even consider to buy TTOO stock.
Good sir, my posting history is entirely irrelevant to the contemporary performance of the TTOO stock price and its attendant consequences for shareholder capital destruction.
Oh…and IRREFUTABLE DUMPING
This sort of scamming company like TTOO does not belongs to Nasdaq.
Some saying Danaher could the potential partner
This looks like it could be under $1 before November 20th. Lost all confidence in this CEO. It seems he is purposely tanking this stock. Maybe he’s got a friend trying to purchase the company cheap.
Post something different you twat. I urge everyone to look at the post history of this person. It's exactly the same over and over
lol I’m listening!!!
It depends if TTOO have anything to offer.Next possibility is to use a name of some big company legally and then only use this ticker as pump a dump scheme.It happens quite often.
A partnership with a big boy Pharma would be well suited as well!
In my opinion buyout is a nonsense as the company is worthless.Maybe some Otc scam would buy it.Who knows
it was discussed today in a twitter channel. check Twitter feeds by searching for $TTOO
where did you read it ? the source ?
Talk of a buyout
If we take a stupid CEO and an unsuccessful, collapsing business, we have the result. The R/S was a last nail not only for shareholders but also for this scam company.
Never pointed finger at retail. They are exhausted on the buy side and 5.00 per takes many out of the game buying power wise.
MMs and hedgies have been screwing around with the PPS and manipulating the stock with naked short selling. I can't see this being retail's fault for this drop. This is not normal
$TTOO - In summary, we achieved important milestones across our three corporate priorities during the third quarter of 2023. Commercially, we continue to increase our global T2Dx Instrument installed base, maintain strong demand for our sepsis test panels, raise awareness of the value of our products directly and through Key Opinion Leaders and Clinical Evaluations at prestigious hospitals like Vanderbilt University Medical Center. Operationally, we strengthened our balance sheet and we made significant progress in in our supply chain and manufacturing operations to address the sepsis test backorder. Scientifically, we received FDA 510(k) clearance for the T2Biothreat Panel, received FDA Breakthrough Device designation for the Candida auris test, filed the FDA 510(k) submission to add detection of Acinetobacter baumannii to the T2Bacteria Panel, and advanced the T2Resistance Panel toward FDA 510(k) submission.
Hope you are correct but I see otherwise. Best
Followers
|
170
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
5811
|
Created
|
12/17/14
|
Type
|
Free
|
Moderators |
This section maintained by INV4 Saving lives and improving healthcare by empowering clinicians to effectively treat patients faster At T2 Biosystems, our mission is to save lives and improve healthcare by empowering clinicians to get patients on the right therapy faster. We come to work every day to solve critical needs in healthcare diagnostics with innovative solutions built on our game-changing T2 Magnetic Resonance (T2MR®) detection technology. Sepsis claims more lives annually than breast cancer, prostate cancer, and AIDS combined. We’re focused on eradicating deaths due to sepsis by developing tools that help identify the most common and deadly sepsis-causing pathogens faster than ever before. Speed is critical in sepsis management. The faster patients receive effective treatment, the more likely they are to survive and have better outcomes. Better yet, early targeted therapy for bloodstream infections may prevent the progression to sepsis altogether. Our blood tests provide actionable results in just 3 to 5 hours. The only other way to identify the species-specific diagnosis requires a blood culture, which can take 1 to 5 days or more. Today, T2 Biosystems panels are getting patients on the right therapy faster, and the expedited identification of negative test results allows rapid de-escalation of unneeded therapy. In partnership with hospitals around the world, T2 Biosystems technology is uniquely positioned to strike a huge blow to sepsis and the hundreds of thousands of lives it takes each year. Our T2Bacteria® and T2Candida® Panels run on the automated T2Dx® Instrument. They are the first and only FDA-cleared blood tests that identify sepsis-causing pathogens without the wait for blood culture. As hospitals continue to adopt our technology, it will represent a paradigm shift that can potentially result in thousands of patients going home to their families instead of the tragic, and potentially avoidable, alternative. We have an active pipeline of future products, including the T2Cauris™ Panel, and T2Lyme™ Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, and biothreat pathogens About our name: T2 refers to the measurement of the reaction of water molecules in the presence of magnetic fields. This is what our T2MR technology measures, and it is the inspiration behind our company’s name. T2Dx Instrument Breakthrough technology enabling direct detection from whole blood The FDA-cleared T2Dx® Instrument is a fully automated, walk away, clinical multiplex benchtop diagnostic system capable of running tests directly from whole blood. The benefits of the T2Dx Instrument include
The T2Dx Instrument serves nearly 200 hospitals worldwide and is powered by T2 Magnetic Resonance (T2MR®) technology. ================================== Innovative T2MR®applications currently in development T2 Biosystems has multiple diagnostic applications in development, all designed to enable further breakthroughs in rapid and accurate therapy for patients. The diagnostics are focused on critical, unmet needs in healthcare, where solutions can serve a dual role of improving patient care while reducing costs. T2Resistance® Panel: T2 Biosystems has partnered with Allergan and CARB-X to develop panels with additional bacterial species and resistance markers. The T2Resistance Panel detects gram-negative and gram-positive resistance markers and is currently available for research use only (RUO) in the U.S. and CE marked on November 20, 2019. T2Cauris™ Panel RUO: Direct detection of the emerging superbug Candida auris in patient skin and blood samples and hospital environmental samples are now available for research use only (RUO) assays. The CDC* validated the T2Cauris Panel RUO swab test on patient skin samples and published their 2017 findings in Mycoses. 1. ANSON FUNDS MANAGEMENT LP Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise investment discretion, over the assets of others, in excess of $100 Million. Major institutions include financial holdings companies, banks, insurance companies, mutual fund managers, portfolio managers, self managed pension and endowment funds. The report is limited to equity securities, including common and equivalents, convertible preferred and convertible bonds. The report does not include fixed income, real estate, or cash equivalents. Reports are filed within 45 days after calendar quarter end with the vast majority of updates occurring near the 45th day of the quarter. About Institutional Holdings Institutional Holdings information can be used to gauge the volatility and value on the company’s stock. https://www.nasdaq.com/market-activity/stocks/ttoo/institutional-holdings Contact 101 Hartwell Avenue |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |